{"id":1430,"date":"2026-04-13T14:10:54","date_gmt":"2026-04-13T14:10:54","guid":{"rendered":"https:\/\/cansaran.com\/?page_id=1430"},"modified":"2026-05-15T13:55:48","modified_gmt":"2026-05-15T13:55:48","slug":"talks","status":"publish","type":"page","link":"https:\/\/cansaran.com\/ru\/about-me\/talks\/","title":{"rendered":"\u0412\u044b\u0441\u0442\u0443\u043f\u043b\u0435\u043d\u0438\u044f"},"content":{"rendered":"<p><strong>\u041c\u0435\u0436\u0434\u0443\u043d\u0430\u0440\u043e\u0434\u043d\u044b\u0435 \u0432\u0441\u0442\u0440\u0435\u0447\u0438<\/strong><\/p>\n<ul>\n<li><strong>Impact of NIRS during cardiac catherization<\/strong> (\u0423\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 Ko\u00e7, 5-\u0439 \u0441\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c: bioengineering approaches on pediatric cardiovascular medicine Ko\u00e7 University, 19 \u0430\u043f\u0440\u0435\u043b\u044f 2013, \u0421\u0442\u0430\u043c\u0431\u0443\u043b)<\/li>\n<li><strong>PDA Closure with vascular plugs<\/strong> (Pediatric And Congenital Interventional Cardiology Symposium Hilton Kozyata\u011f\u0131, \u0421\u0442\u0430\u043c\u0431\u0443\u043b; 11-13 \u043c\u0430\u044f 2017)<\/li>\n<li><strong>A New Device for Ventricular Septal Defect Closure: Lifetech MFO <\/strong>(China Heart Congress (CHC), \u0428\u044d\u043d\u044c\u0447\u0436\u044d\u043d\u044c, \u041a\u0438\u0442\u0430\u0439; 1-3 \u043d\u043e\u044f\u0431\u0440\u044f 2019)<\/li>\n<li><strong>How accurate is Echo in predicting the size and shape of Device? <\/strong>(\u0412\u0441\u0442\u0440\u0435\u0447\u0430 CASPIAN, \u041c\u0435\u0448\u0445\u0435\u0434, \u0418\u0440\u0430\u043d, 24-16 \u043c\u0430\u044f 2023)<\/li>\n<li><strong>RVOT stenting in cyanotic infants; When and how ? <\/strong>(4<sup>th<\/sup> China Structural Heart Disease Congress (CSHC), \u041f\u0435\u043a\u0438\u043d, \u041a\u0438\u0442\u0430\u0439, 31 \u043c\u0430\u0440\u0442\u0430 &#8212; 2 \u0430\u043f\u0440\u0435\u043b\u044f)<\/li>\n<li><strong>Never Lose The Wire Position. <\/strong>(\u0412\u0441\u0442\u0440\u0435\u0447\u0430 CASPIAN, \u041c\u0435\u0448\u0445\u0435\u0434, \u0418\u0440\u0430\u043d, 11-14 \u0430\u043f\u0440\u0435\u043b\u044f 2024)<\/li>\n<li><strong>PDA vs RVOT stent; When I do PDA stent? <\/strong>(\u0412\u0441\u0442\u0440\u0435\u0447\u0430 CASPIAN, \u041c\u0435\u0448\u0445\u0435\u0434, \u0418\u0440\u0430\u043d, 11-14 \u0430\u043f\u0440\u0435\u043b\u044f 2024)<\/li>\n<li><strong>Percutaneous and Non-Fluoroscopic Procedure in Turkey: The Future ExpectsI nternational <\/strong>Scientific Symposium on Percutaneous and Non-Fluoroscopic Procedure (PAN-Procedure) 19-20 \u0430\u043f\u0440\u0435\u043b\u044f 2024, \u0421\u0422\u0410\u041c\u0411\u0423\u041b, \u0422\u0423\u0420\u0426\u0418\u042f<\/li>\n<li><strong>The PAN Procedure in Turkey: Current Practice and Future <u>Expects<\/u> <\/strong>Regional Scientific Symposium on the Percutaneous and Non-Fluoroscopic (PAN) Procedure, 1 \u043c\u0430\u044f 2025, \u0422\u0430\u0448\u043a\u0435\u043d\u0442, \u0423\u0437\u0431\u0435\u043a\u0438\u0441\u0442\u0430\u043d<\/li>\n<li><strong>Right Ventricular Outflow Tract Stenting In Cyanotic Infants: When And How?<\/strong> \u041c\u0438\u043d\u0438\u0441\u0442\u0435\u0440\u0441\u0442\u0432\u043e \u0437\u0434\u0440\u0430\u0432\u043e\u043e\u0445\u0440\u0430\u043d\u0435\u043d\u0438\u044f \u0420\u0435\u0441\u043f\u0443\u0431\u043b\u0438\u043a\u0438 \u0423\u0437\u0431\u0435\u043a\u0438\u0441\u0442\u0430\u043d, \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u0434\u0435\u0442\u0441\u043a\u0438\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0446\u0435\u043d\u0442\u0440, \u0441\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u043f\u043e \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 2-3 \u043c\u0430\u044f 2025, \u0422\u0430\u0448\u043a\u0435\u043d\u0442, \u0423\u0437\u0431\u0435\u043a\u0438\u0441\u0442\u0430\u043d<\/li>\n<li><strong>Free floating Occluder device in LA, a time for fishing,<\/strong> Caspian Challenging cases, 18-21 \u0438\u044e\u043d\u044f 2025, CSI Frankfurt<\/li>\n<\/ul>\n<p><strong> <\/strong><\/p>\n<p><strong>\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0435 \u0432\u0441\u0442\u0440\u0435\u0447\u0438<\/strong><\/p>\n<ul>\n<li><strong>Preoperative evaluation of the pediatric cardiac patient<\/strong> (7-\u0439 \u0421\u0442\u0430\u043c\u0431\u0443\u043b\u044c\u0441\u043a\u0438\u0439 \u0441\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c, \u043c\u0443\u043b\u044c\u0442\u0438\u0434\u0438\u0441\u0446\u0438\u043f\u043b\u0438\u043d\u0430\u0440\u043d\u044b\u0439 \u043f\u043e\u0434\u0445\u043e\u0434 \u043a \u0440\u0430\u0437\u0432\u0438\u0442\u0438\u044e \u043f\u0435\u0434\u0438\u0430\u0442\u0440\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438 \u0438 \u043f\u0440\u043e\u0446\u0435\u0434\u0443\u0440\u044b \u043a\u0430\u0440\u0434\u0438\u043e\u043f\u0443\u043b\u044c\u043c\u043e\u043d\u0430\u043b\u044c\u043d\u043e\u0433\u043e bypass \u0432 \u0422\u0443\u0440\u0446\u0438\u0438 \u0438 \u0441\u043d\u0438\u0436\u0435\u043d\u0438\u044e \u0447\u0430\u0441\u0442\u043e\u0442\u044b \u043e\u0441\u043b\u043e\u0436\u043d\u0435\u043d\u0438\u0439, \u0423\u0447\u0435\u0431\u043d\u043e-\u0438\u0441\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u0442\u0435\u043b\u044c\u0441\u043a\u0430\u044f \u0431\u043e\u043b\u044c\u043d\u0438\u0446\u0430 \u0432\u044b\u0441\u043e\u043a\u043e\u0439 \u0441\u043f\u0435\u0446\u0438\u0430\u043b\u0438\u0437\u0430\u0446\u0438\u0438 Kartal Ko\u015fuyolu, 28 \u0441\u0435\u043d\u0442\u044f\u0431\u0440\u044f 2013)<\/li>\n<li><strong>Low cardiac output; diagnosis and follow-up<\/strong> (\u041a\u0443\u0440\u0441 \u0441\u0435\u0441\u0442\u0440\u0438\u043d\u0441\u043a\u043e\u0433\u043e \u0443\u0445\u043e\u0434\u0430 \u0432 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0438\u043d\u0442\u0435\u043d\u0441\u0438\u0432\u043d\u043e\u0439 \u0442\u0435\u0440\u0430\u043f\u0438\u0438 \u043f\u0440\u0438 \u0432\u0440\u043e\u0436\u0434\u0451\u043d\u043d\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u0445 \u0441\u0435\u0440\u0434\u0446\u0430. 11 \u043c\u0430\u044f 2017, \u0421\u0442\u0430\u043c\u0431\u0443\u043b)<\/li>\n<li><strong>Post Glenn follow-up; complications and treatment. Optimal Fontan time <\/strong>(2-\u0439 \u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0433\u043e \u0441\u0435\u0440\u0434\u0446\u0430. \u041a\u0430\u043a \u0441\u043b\u0435\u0434\u0443\u0435\u0442 \u043d\u0430\u0431\u043b\u044e\u0434\u0430\u0442\u044c \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u043f\u043e\u0441\u043b\u0435 \u043e\u043f\u0435\u0440\u0430\u0446\u0438\u0438 \u0438 \u0438\u043d\u0442\u0435\u0440\u0432\u0435\u043d\u0446\u0438\u043e\u043d\u043d\u043e\u0433\u043e \u043b\u0435\u0447\u0435\u043d\u0438\u044f? \u041f\u043e\u0432\u0442\u043e\u0440\u043d\u043e\u0435 \u0432\u043c\u0435\u0448\u0430\u0442\u0435\u043b\u044c\u0441\u0442\u0432\u043e; \u043a\u043e\u0433\u0434\u0430 \u0438 \u043a\u0430\u043a? 14 \u043e\u043a\u0442\u044f\u0431\u0440\u044f 2017, \u0421\u0442\u0430\u043c\u0431\u0443\u043b)<\/li>\n<li><strong>Hemodynamic evaluation of the univentricular patient before surgical repair <\/strong>(\u041a\u0443\u0440\u0441 \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u0447\u0435\u0441\u043a\u043e\u0439 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e\u0439 \u043a\u0430\u0442\u0435\u0442\u0435\u0440\u0438\u0437\u0430\u0446\u0438\u0438 \u043f\u0440\u0438 \u0432\u0440\u043e\u0436\u0434\u0451\u043d\u043d\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f\u0445 \u0441\u0435\u0440\u0434\u0446\u0430, 13 \u044f\u043d\u0432\u0430\u0440\u044f 2018, \u0421\u0442\u0430\u043c\u0431\u0443\u043b)<\/li>\n<li><strong>Transcatheter interventions after aortic surgery in children. <\/strong> \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 18-21 \u0430\u043f\u0440\u0435\u043b\u044f 2017, \u0410\u043d\u0442\u0430\u043b\u044c\u044f, \u0422\u0443\u0440\u0446\u0438\u044f)<\/li>\n<li><strong>RVOT stenting in cyanotic tetralogy of Fallot; when and how? <\/strong>\u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 (G\u0130PEKS), 23-24 \u043d\u043e\u044f\u0431\u0440\u044f 2018, \u0421\u0422\u0410\u041c\u0411\u0423\u041b<\/li>\n<li><strong>Off-label devices and device selection for PDA closure.<\/strong> \u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0433\u043e \u0441\u0435\u0440\u0434\u0446\u0430, 5 \u043e\u043a\u0442\u044f\u0431\u0440\u044f 2019, \u0421\u0442\u0430\u043c\u0431\u0443\u043b<\/li>\n<li><strong>TEE Guidance before and during ASD closure <\/strong> \u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0433\u043e \u0441\u0435\u0440\u0434\u0446\u0430, 5 \u043e\u043a\u0442\u044f\u0431\u0440\u044f 2019, \u0421\u0442\u0430\u043c\u0431\u0443\u043b<\/li>\n<li><strong>Non-floroscopic ASD closure.<\/strong> \u041f\u0440\u043e\u0434\u0432\u0438\u043d\u0443\u0442\u044b\u0439 \u043a\u0443\u0440\u0441 \u0437\u0430\u043a\u0440\u044b\u0442\u0438\u044f ASD, 21 \u0434\u0435\u043a\u0430\u0431\u0440\u044f 2019, \u0421\u0442\u0430\u043c\u0431\u0443\u043b<\/li>\n<li><strong>Agents used in PAH treatment, <\/strong>\u0412\u0441\u0442\u0440\u0435\u0447\u0430 \u0440\u0430\u0431\u043e\u0447\u0435\u0439 \u0433\u0440\u0443\u043f\u043f\u044b \u043f\u043e \u043b\u0451\u0433\u043e\u0447\u043d\u043e\u0439 \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u0438 \u0438 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e\u0439 \u043d\u0435\u0434\u043e\u0441\u0442\u0430\u0442\u043e\u0447\u043d\u043e\u0441\u0442\u0438, 8 \u044f\u043d\u0432\u0430\u0440\u044f 2020<\/li>\n<li><strong>Cardiac catheterization and, hemodynamic evaluation with examples.<\/strong> \u041a\u0443\u0440\u0441 \u0437\u0430\u043a\u0440\u044b\u0442\u0438\u044f ASD, 21 \u0444\u0435\u0432\u0440\u0430\u043b\u044f 2020, \u0421\u0442\u0430\u043c\u0431\u0443\u043b<\/li>\n<li><strong>Embolized central catheter. What to do? When we should consider operation?<\/strong> \u041a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u00c7ocuk Dostlar\u0131, 12-14 \u043c\u0430\u0440\u0442\u0430 2020, \u0421\u0442\u0430\u043c\u0431\u0443\u043b<\/li>\n<li><strong>Stenting the RVOT in cyanotic infants, when and how?<\/strong> \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 23-25 \u043e\u043a\u0442\u044f\u0431\u0440\u044f 2020, \u0410\u043d\u0442\u0430\u043b\u044c\u044f, \u0422\u0443\u0440\u0446\u0438\u044f)<\/li>\n<li><strong>PDA closure with PDA closure devices and off-label devices <\/strong>(5-\u0439 \u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0433\u043e \u0441\u0435\u0440\u0434\u0446\u0430, 3 \u0430\u043f\u0440\u0435\u043b\u044f 2021)<\/li>\n<li><strong>First stage palliations in single ventricle patients. <\/strong>\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 10-13 \u043c\u0430\u0440\u0442\u0430 2022, \u0410\u043d\u0442\u0430\u043b\u044c\u044f, \u0422\u0443\u0440\u0446\u0438\u044f)<\/li>\n<li><strong>Basic technical features in echocardiography <\/strong> \u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0433\u043e \u0441\u0435\u0440\u0434\u0446\u0430, 22 \u043e\u043a\u0442\u044f\u0431\u0440\u044f 2022, \u0410\u043d\u043a\u0430\u0440\u0430<\/li>\n<li><strong>Pulmonary vasculary resistans Calculation in multiple shunt patients.<\/strong> \u0412\u0441\u0442\u0440\u0435\u0447\u0430 \u0440\u0430\u0431\u043e\u0447\u0435\u0439 \u0433\u0440\u0443\u043f\u043f\u044b \u043f\u043e \u043b\u0451\u0433\u043e\u0447\u043d\u043e\u0439 \u0433\u0438\u043f\u0435\u0440\u0442\u0435\u043d\u0437\u0438\u0438 \u0438 \u0441\u0435\u0440\u0434\u0435\u0447\u043d\u043e\u0439 \u043d\u0435\u0434\u043e\u0441\u0442\u0430\u0442\u043e\u0447\u043d\u043e\u0441\u0442\u0438, 24 \u0434\u0435\u043a\u0430\u0431\u0440\u044f 2022<\/li>\n<li><strong>How to reduce radiation exposure for both patients and clinicians. <\/strong>\u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 27-30 \u0430\u043f\u0440\u0435\u043b\u044f 2023, \u0410\u043d\u0442\u0430\u043b\u044c\u044f, \u0422\u0443\u0440\u0446\u0438\u044f<\/li>\n<li><strong>Hybrid Interventions in Congenital Heart Diseases \u2013 Other Hybrid Interventions and the Future Aspects,<\/strong> \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 7-10 \u043c\u0430\u0440\u0442\u0430 2024, \u0410\u043d\u0442\u0430\u043b\u044c\u044f, \u0422\u0443\u0440\u0446\u0438\u044f<\/li>\n<li><strong>Complications of vascular access and how to manage them<\/strong>\u2013 (5-\u0439 \u0421\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c \u0434\u0435\u0442\u0441\u043a\u043e\u0433\u043e \u0441\u0435\u0440\u0434\u0446\u0430, 3 \u0430\u043f\u0440\u0435\u043b\u044f 2021)<\/li>\n<li><strong>Complications of Transcatheter Pulmonary Valve Implantation<\/strong> \u041d\u0430\u0446\u0438\u043e\u043d\u0430\u043b\u044c\u043d\u044b\u0439 \u043a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u0434\u0435\u0442\u0441\u043a\u043e\u0439 \u043a\u0430\u0440\u0434\u0438\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u0438, 17-20 \u0430\u043f\u0440\u0435\u043b\u044f 2025, \u0410\u043d\u0442\u0430\u043b\u044c\u044f, \u0422\u0443\u0440\u0446\u0438\u044f<\/li>\n<li><strong>Evaluation of Conduit and Shunt Flows with Suprasternal Examination,<\/strong> 7-\u0439 \u041a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u043b\u0451\u0433\u043e\u0447\u043d\u044b\u0445 \u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439, 8-10 \u043c\u0430\u044f 2025, \u043a\u0443\u0440\u0441 \u044d\u0445\u043e\u043a\u0430\u0440\u0434\u0438\u043e\u0433\u0440\u0430\u0444\u0438\u0447\u0435\u0441\u043a\u043e\u0433\u043e \u043e\u0431\u0441\u043b\u0435\u0434\u043e\u0432\u0430\u043d\u0438\u044f, \u0421\u0442\u0430\u043c\u0431\u0443\u043b, \u0422\u0443\u0440\u0446\u0438\u044f<\/li>\n<li><strong>Adult Congenital Heart Diseases Session: Late-Term Repairs and Reoperations,<\/strong> 7-\u0439 \u041a\u043e\u043d\u0433\u0440\u0435\u0441\u0441 \u043b\u0451\u0433\u043e\u0447\u043d\u044b\u0445 \u0441\u043e\u0441\u0443\u0434\u0438\u0441\u0442\u044b\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439, 8-10 \u043c\u0430\u044f 2025, \u0421\u0442\u0430\u043c\u0431\u0443\u043b, \u0422\u0443\u0440\u0446\u0438\u044f<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u041c\u0435\u0436\u0434\u0443\u043d\u0430\u0440\u043e\u0434\u043d\u044b\u0435 \u0432\u0441\u0442\u0440\u0435\u0447\u0438 Impact of NIRS during cardiac catherization (\u0423\u043d\u0438\u0432\u0435\u0440\u0441\u0438\u0442\u0435\u0442 Ko\u00e7, 5-\u0439 \u0441\u0438\u043c\u043f\u043e\u0437\u0438\u0443\u043c: bioengineering approaches on pediatric cardiovascular medicine Ko\u00e7 University, 19 \u0430\u043f\u0440\u0435\u043b\u044f 2013, \u0421\u0442\u0430\u043c\u0431\u0443\u043b) PDA Closure with vascular plugs (Pediatric And Congenital Interventional Cardiology Symposium Hilton Kozyata\u011f\u0131, \u0421\u0442\u0430\u043c\u0431\u0443\u043b; 11-13 \u043c\u0430\u044f 2017) A New Device for Ventricular Septal Defect Closure: Lifetech MFO (China Heart Congress (CHC), [&#8230;]\n","protected":false},"author":1,"featured_media":0,"parent":1413,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-blank-title-center.php","meta":{"footnotes":""},"class_list":["post-1430","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/pages\/1430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/comments?post=1430"}],"version-history":[{"count":2,"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/pages\/1430\/revisions"}],"predecessor-version":[{"id":1432,"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/pages\/1430\/revisions\/1432"}],"up":[{"embeddable":true,"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/pages\/1413"}],"wp:attachment":[{"href":"https:\/\/cansaran.com\/ru\/wp-json\/wp\/v2\/media?parent=1430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}